Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000588245 | SCV000234910 | likely benign | not provided | 2020-09-25 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 23142374, 26017485, 27647783) |
Labcorp Genetics |
RCV001082621 | SCV000556092 | likely benign | Aortic aneurysm, familial thoracic 4 | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000588245 | SCV000697648 | benign | not provided | 2016-02-22 | criteria provided, single submitter | clinical testing | Variant summary: This c.4694C>T variant affects a conserved nucleotide, resulting in amino acid change from Thr to Met. 3/4 in-silico tools predict this variant to be damaging; however they are not definite. This variant was found in 94/122406 control chromosomes at a frequency of 0.0007679, which is more than 613 times greater than the maximal expected frequency of a pathogenic allele (0.0000013) in this gene, suggesting this variant is benign. At least one clinical lab has classified this variant as likely benign. Taken together, this variant has been classified as Benign. |
Ambry Genetics | RCV000157333 | SCV000739212 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2018-05-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000588245 | SCV001249512 | likely benign | not provided | 2023-03-01 | criteria provided, single submitter | clinical testing | MYH11: PP3, BS1 |
Illumina Laboratory Services, |
RCV001082621 | SCV001277601 | benign | Aortic aneurysm, familial thoracic 4 | 2017-09-14 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. |
CHEO Genetics Diagnostic Laboratory, |
RCV000157333 | SCV001333420 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2018-10-30 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000157333 | SCV001344866 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2018-10-24 | criteria provided, single submitter | clinical testing | |
Department of Vascular Biology, |
RCV001374830 | SCV001439579 | uncertain significance | Isolated thoracic aortic aneurysm | 2018-09-01 | criteria provided, single submitter | research | |
ARUP Laboratories, |
RCV000588245 | SCV004562768 | likely benign | not provided | 2023-05-02 | criteria provided, single submitter | clinical testing | |
Blueprint Genetics | RCV000157333 | SCV000207070 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2014-11-03 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003927518 | SCV004746586 | likely benign | MYH11-related disorder | 2022-12-21 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |